Clari Vest Asset Management LLC Agenus Inc Transaction History

Clari Vest Asset Management LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$1.31 - $2.04 $52,485 - $81,732	40,065 Added 8.42%	515,990 $825,000
Q1 2023 May 08, 2023	BUY	$1.45 - $2.95 $765 - $1,557	528 Added 0.11%	475,925 $724,000
Q4 2022 Feb 14, 2023	SELL	$2.02 - $3.25 $8,193 - $13,182	-4,056 Reduced 0.85%	475,397 $1.14 Million
Q3 2022 Nov 10, 2022	BUY	$1.96 - $3.14 $87,909 - $140,835	44,852 Added 10.32%	479,453 $983,000
Q2 2022 Aug 12, 2022	BUY	$1.3 - $2.64 $83,007 - $168,569	63,852 Added 17.22%	434,601 $843,000
Q1 2022 May 04, 2022	BUY	$2.35 - $3.47 $343,920 - $507,831	146,349 Added 65.22%	370,749 $912,000
Q4 2021 Feb 14, 2022	BUY	$2.92 - $5.74 $655,248 - $1.29 Million	224,400 New	224,400 $722,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Clari Vest Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Clari Vest Asset Management LLC with notifications on news.